Subscribe
shutterstock_687616957_sean_pavone
Sean Pavone / Shutterstock.com
22 August 2023Big PharmaMarisa Woutersen

Foley Hoag adds partner in Boston

Biologics patent attorney aims to strengthen the firm’s global patent networks.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
Hogan Lovells adds tech partner to Boston office
8 September 2022   Law firm Hogan Lovells has hired Chris Natkanski to its global regulatory and intellectual property, media, and technology practice group in Boston.
Big Pharma
GSK bets $2.1bn on Boston-based biopharma company
1 June 2022   GlaxoSmithKline has agreed to acquire Affinivax, a clinical-stage biopharmaceutical company based in Cambridge, Boston and focusing on developing vaccines.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

article
Hogan Lovells adds tech partner to Boston office
8 September 2022   Law firm Hogan Lovells has hired Chris Natkanski to its global regulatory and intellectual property, media, and technology practice group in Boston.
Big Pharma
GSK bets $2.1bn on Boston-based biopharma company
1 June 2022   GlaxoSmithKline has agreed to acquire Affinivax, a clinical-stage biopharmaceutical company based in Cambridge, Boston and focusing on developing vaccines.

More on this story

article
Hogan Lovells adds tech partner to Boston office
8 September 2022   Law firm Hogan Lovells has hired Chris Natkanski to its global regulatory and intellectual property, media, and technology practice group in Boston.
Big Pharma
GSK bets $2.1bn on Boston-based biopharma company
1 June 2022   GlaxoSmithKline has agreed to acquire Affinivax, a clinical-stage biopharmaceutical company based in Cambridge, Boston and focusing on developing vaccines.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?